Stocks · News reference
Stratasys, Limbitless Solution Expand 12-Year Partnership Over 3D-Printed Prosthetic Devices
Stratasys Ltd. (NASDAQ:SSYS), a global leader in additive manufacturing solutions, and Limbitless Solutions, a nonprofit research facility at the University of Central Florida dedicated to empowering children through
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Stratasys Launches Its F870 FDM System Large-Format Additive Manufacturing Platform At Toyota And Rivian Factories In The U.S.
Extending the Stratasys production-grade FDM portfolio, the F870 combines unrivaled large-format capabilities in a heated chamber backed by a suite of the strongest, most durable materials, all with a lower total cost
Correction: Bioprinting Market to Reach $5.1 Billion by 2030, Driven by Regenerative Medicine Demand and AI Integration
The global bioprinting market is projected to grow from $2.1 billion in 2024 to $5.1 billion by 2030 at a 16.1% CAGR, driven by regenerative medicine demand, pharmaceutical adoption for drug discovery, reduced animal testing, and AI integration. North America leads with 38% market share, while emerging technologies like 4D bioprinting and organ-on-chip devices expand market boundaries.